Baylor Research Institute appoints Yong-Jun Liu as VP, CSO

Friday, April 29, 2011 12:20 PM

Baylor Research Institute (BRI), the research arm of Baylor Health Care System (BHCS), has appointed Yong-Jun Liu, M.D., Ph.D., vice president and chief scientific officer (CSO) for BRI and director of the Baylor Institute for Immunology Research (BIIR).

Liu comes to Baylor from the University of Texas M.D. Anderson Cancer Center where he was professor and chair of the department of immunology as well as the director of the center for cancer immunology research.  Before that, he was senior staff scientist at the biotech company DNAX Research Institute of Molecular and Cellular Biology.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs